Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Iovance Biotherapeutics Inc. buy Chardan Capital

Iovance Biotherapeutics Inc.
Start price
€6.85
01.03.23 / 50%
Target price
€27.17
01.03.24
Performance (%)
127.70%
End price
€15.60
02.03.24
Summary
This prediction ended on 02.03.24 with a price of €15.60. With a performance of 127.70% the BUY prediction by Chardan_Capital was a big success. Chardan_Capital has a follow-up prediction for Iovance Biotherapeutics Inc. where he still thinks Iovance Biotherapeutics Inc. is a Buy. Chardan_Capital has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Iovance Biotherapeutics Inc. 8.007% 8.007% 183.844% 8.626%
iShares Core DAX® -0.874% 5.325% 6.865% 65.211%
iShares Nasdaq 100 -0.381% 1.979% 25.696% 90.325%
iShares Nikkei 225® -1.676% 1.952% 41.443% 80.623%
iShares S&P 500 -0.655% 2.069% 21.405% 70.737%

Comments by Chardan_Capital for this prediction

In the thread Iovance Biotherapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 127.70%
Target price 27.167
Change
Ends at 01.03.24

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $29.00 price target on the stock.
Ratings data for IOVA provided by MarketBeat

Chardan Capital 
0
Report Share
01.03.23
In the thread Trading Iovance Biotherapeutics Inc.
Prediction Buy
Perf. (%) 127.70%
Target price 27.167
Change
Ends at 01.03.24

Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten

Chardan Capital 
0
Report Share
02.03.24

Current prediction by Chardan_Capital for Iovance Biotherapeutics Inc.

buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€3.53
25.02.26
€13.57
25.02.27
86.69%
17:08

Chardan Capital 
25.02.26 50%

Stopped prediction by Chardan_Capital for Iovance Biotherapeutics Inc.

buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€2.90
08.05.26
€11.94
08.05.27
128.97%
17:08

Chardan Capital 
08.05.26 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€3.16
10.04.26
€13.69
10.04.27
108.87%
17:08

Chardan Capital 
10.04.26 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.93
08.08.25
€17.15
08.08.26
178.90%
09.08.26

Chardan Capital 
08.08.25 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€3.23
23.07.25
€21.30
23.07.26
38.08%
24.07.26

Chardan Capital 
23.07.25 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.52
09.05.25
€22.29
09.05.26
104.02%
10.05.26

Chardan Capital 
09.05.25 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€4.03
03.03.25
€28.64
03.03.26
-21.65%
04.03.26

Chardan Capital 
03.03.25 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€10.58
20.02.24
€31.41
20.02.25
-47.83%
21.02.25

Chardan Capital 
20.02.24 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€6.53
16.08.23
€26.61
16.08.24
46.63%
17.08.24

Chardan Capital 
16.08.23 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€6.49
10.08.23
€26.26
10.08.24
40.01%
11.08.24

Chardan Capital 
10.08.23 50%